MFIM
NAGE

Mesirow Financial Investment Management’s Niagen Bioscience NAGE Stock Holding History

Mesirow Financial Investment Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,029
Closed -$19K – 132
2021
Q1 		$19K Buy
2,029
+869
+75% +$6.89K 0.05% 93
2020
Q4 		$5.57K Buy
+1,160
New +$5.66K 0.02% 118

Other funds holding NAGE

YRHAM
Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $119M AUM 233.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mesirow Financial Investment Management's NAGE Position: Q2 2021 in Review

Mesirow Financial Investment Management sold out of Niagen Bioscience (NAGE) in Q2 2021, closing a stake of 2,029 shares — an estimated $19K sold.

Mesirow Financial Investment Management first reported a position in NAGE in Q4 2020 and held it in 2 quarters. The position peaked at $19K in Q1 2021. 101 funds tracked by Wall St. Rank hold NAGE as of Q2 2021.

  • Mesirow Financial Investment Management reported no remaining Niagen Bioscience position as of Q2 2021 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 2,029 Niagen Bioscience shares in Q2 2021, an estimated $19K.
  • Mesirow Financial Investment Management first reported a position in Niagen Bioscience in Q4 2020 and held it in 2 quarters.
  • Mesirow Financial Investment Management's Niagen Bioscience position peaked at $19K in Q1 2021.
  • 101 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2021.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2021, filed 23 Jul 2021.